6,2',4'-trimethoxyflavone

structure in first source

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

1.	Obesity 01/05/2023 - "In this study, the anti-obesity effects of 5,7,3',4',5-pentamethoxyflavone (PMF) and 6,2',4'-trimethoxyflavone (TMF) were evaluated through two distinct mechanisms of action: inhibition of crude porcine pancreatic lipase (PL), and inhibition of adipogenesis in 3T3-L1 pre-adipocytes. "
2.	Ischemia 05/01/2023 - "We administered 6,2',4'-trimethoxyflavone (TMF, 5 mg/kg) intraperitoneally 10 min after ischemia. "
3.	Glioma (Gliomas) 10/01/2019 - "To determine the significance of the AHR pathway in LN-18 and T98G glioma inflammatory profiles, and on the effects of E804 and 7BIO on these profiles, we used 6,2',4'-trimethoxyflavone (TMF), a putative selective AHR antagonist. "

1.	Lipase (Acid Lipase)